작성일
2024.03.12
수정일
2024.03.12
작성자
세포교신제어연구센터
조회수
24

Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer

논문제목: Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer

년도
2023
참여교수
홍순선
게재지
Biomedicine & Pharmacotherapy
링크
https://pubmed.ncbi.nlm.nih.gov/37086509/